71 related articles for article (PubMed ID: 20367263)
1. Recovery of humoral and cellular immunities to vaccine-preventable infectious diseases in pediatric oncology patients.
Cheng FW; Leung TF; Chan PK; Leung WK; Lee V; Shing MK; Yuen PM; Li CK
Pediatr Hematol Oncol; 2010 Apr; 27(3):195-204. PubMed ID: 20367263
[TBL] [Abstract][Full Text] [Related]
2. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients.
Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK
Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325
[TBL] [Abstract][Full Text] [Related]
3. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy.
Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S
Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078
[TBL] [Abstract][Full Text] [Related]
4. Diphtheria (D) and tetanus (T) antibody values in children with acute lymphoblastic leukaemia (ALL) after treatment according to Co-ALL 05/92.
Calaminus G; Hense B; Laws HJ; Groeger M; MacKenzie CR; Göbel U
Klin Padiatr; 2007; 219(6):355-60. PubMed ID: 18050047
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL.
Kosmidis S; Baka M; Bouhoutsou D; Doganis D; Kallergi C; Douladiris N; Pourtsidis A; Varvoutsi M; Saxoni-Papageorgiou F; Vasilatou-Kosmidis H
Pediatr Blood Cancer; 2008 Mar; 50(3):528-32. PubMed ID: 17853465
[TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT).
Reimer P; Kunzmann V; Wilhelm M; Weissbrich B; Kraemer D; Berghammer H; Weissinger F
Ann Hematol; 2003 May; 82(5):263-70. PubMed ID: 12739062
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
[TBL] [Abstract][Full Text] [Related]
9. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
[TBL] [Abstract][Full Text] [Related]
10. Humoral immunity to diphtheria, tetanus, measles, and hemophilus influenzae type b in children with acute lymphoblastic leukemia and response to re-vaccination.
Zengin E; Sarper N
Pediatr Blood Cancer; 2009 Dec; 53(6):967-72. PubMed ID: 19544393
[TBL] [Abstract][Full Text] [Related]
11. Increase of circulating CD8+CD57+ lymphocytes after measles infection but not after measles vaccination.
Aronsson B; Troye-Blomberg M; Smedman L
J Clin Lab Immunol; 2004-2005; 53():1-12. PubMed ID: 16805321
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
13. Humoral immunity against hepatitis B, tetanus, and diphtheria following chemotherapy for hematologic malignancies: a report and review of literature.
Alavi S; Rashidi A; Arzanian MT; Shamsian B; Nourbakhsh K
Pediatr Hematol Oncol; 2010 Apr; 27(3):188-94. PubMed ID: 20367262
[TBL] [Abstract][Full Text] [Related]
14. [Vaccination].
Graubner UB; Liese J; Belohradsky BH
Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis.
Grzegorzewska AE; Leander M
Adv Perit Dial; 2001; 17():10-4. PubMed ID: 11510253
[TBL] [Abstract][Full Text] [Related]
16. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
[TBL] [Abstract][Full Text] [Related]
17. Impact of treatment reduction for childhood acute lymphoblastic leukemia on serum immunoglobulins and antibodies against vaccine-preventable diseases.
van Tilburg CM; Bierings MB; Berbers GA; Wolfs TF; Pieters R; Bloem AC; Sanders EA
Pediatr Blood Cancer; 2012 May; 58(5):701-7. PubMed ID: 21793184
[TBL] [Abstract][Full Text] [Related]
18. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of long-term impacts of tonsillectomy on immune functions of children: a follow-up study.
Kaygusuz I; Alpay HC; Gödekmerdan A; Karlidag T; Keles E; Yalcin S; Demir N
Int J Pediatr Otorhinolaryngol; 2009 Mar; 73(3):445-9. PubMed ID: 19150575
[TBL] [Abstract][Full Text] [Related]
20. Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.
Guerra FA; Gress J; Werzberger A; Reisinger K; Walter E; Lakkis H; Grosso AD; Welebob C; Kuter BJ;
Pediatr Infect Dis J; 2006 Oct; 25(10):912-9. PubMed ID: 17006287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
